KRAS and lung adenocarcinoma: Our cases not only confirm various claims made by earlier studies regarding KRAS G12C mutations but also present the first documentation highlighting and describing the cases of KRAS G12C-mutant lung adenocarcinoma in patients, which have been possibly missing because of a lack of research.